#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Cardiology Review - Issue 2/2012

63

Antiaggregating and anticoagulant therapy – basic principles

M. Penka

68

Oral antiplatelet therapy in patients with acute coronary syndrome

R. Štípal

72

Current guidelines for antiplatelet therapy in neurology

R. Herzig, M. Král

79

Anticoagulant therapy and atrial fibrillation

R. Lábrová, J. Špinar

88

New peroral antithrombotics in the prevention and treatment of tromboembolism

D. Karetová, J. Bultas

93

New antithrombotic drugs in the prophylaxis of postoperative venous thromboembolism

P. Kessler

97

Current possibilities of monitoring of antithrombotic therapy – new antithrombotic drugs

A. Buliková, J. Zavřelová, M. Matýšková

103

Where is a step in the current development of drugs that affect blood clotting?

J. Kvasnička

Reports from Foreign countries

109

Vorapaxar in clinical studies

J. Špinar, J. Vítovec, L. Špinarová

115

What is vernakalant and what is its place in clinical practice?

J. Murín, J. Vítovec

121

Eprosartan – dual blocker of AT₁ receptors

J. Špinar, J. Vítovec, L. Špinarová

Case Report

126

Multiple administration of medication and circulatory failure for malignant ventricular arrhythmias and impairment of liver function

J. Vítovec, K. Židová

Case report - competitive

130

Heart Transplant Patient with Invasive Pulmonary Aspergillosis

P. Šajgalík, L. Špinarová, P. Hude, J. Krejčí, J. Godava, M. Tošková, Z. Ráčil, J. Vítovec, P. Němec

Cardiology Review

Issue 2

2012 Issue 2

Most read in this issue

#ADS_BOTTOM_SCRIPTS#